Wedbush Securities’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $37K | Hold |
|
|||||
|
2023
Q4 | $26K | Hold |
|
|||||
|
2023
Q3 | $30K | Hold |
|
|||||
|
2023
Q2 | $22K | Hold |
|
|||||
|
2023
Q1 | $33K | Sell |
|
|||||
|
2022
Q4 | $28K | Sell |
|
|||||
|
2022
Q3 | $41K | Sell |
|
|||||
|
2022
Q2 | $37K | Hold |
|
|||||
|
2022
Q1 | $45K | Sell |
|
|||||
|
2021
Q4 | $62K | Sell |
|
|||||
|
2021
Q3 | $120K | Buy |
|
|||||
|
2021
Q2 | $58K | Hold |
|
|||||
|
2021
Q1 | $39K | Sell |
|
|||||
|
2020
Q4 | $46K | Buy |
|
|||||
|
2020
Q3 | $47K | Sell |
|
|||||
|
2020
Q2 | $63K | Hold |
|
|||||
|
2020
Q1 | $40K | Sell |
|
|||||
|
2019
Q4 | $61K | Hold |
|
|||||
|
2019
Q3 | $79K | Sell |
|
|||||
|
2019
Q2 | $102K | Buy |
|
|||||
|
2019
Q1 | $92K | Hold |
|
|||||
|
2018
Q4 | $62K | Hold |
|
|||||
|
2018
Q3 | $108K | Hold |
|
|||||
|
2018
Q2 | $114K | Sell |
|
|||||
|
2018
Q1 | $171K | Buy |
|
|||||
|
2017
Q4 | $102K | Buy |
|